225Ac-ELI-201

N/A

Report date: 2026/03/31 11:24:26

Base Information

Drug Name225Ac-ELI-201

Drug Alias Name225Ac-ELI-201

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHangzhou Eli Radiopharma Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Eli Radiopharma Co Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A